Dr. Aghalar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 Route 112
Building 4 Suite101
Port Jefferson, NY 11776Phone+1 631-751-3000
Education & Training
Zucker School of Medicine at Hofstra/NorthwellFellowship, Hematology and Medical Oncology, 2011 - 2014- Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 2007 - 2010
Albert Einstein College of MedicineClass of 2007
Certifications & Licensure
NY State Medical License 2008 - 2026- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 214 citationsRandomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma.Sean McBride, Eric J. Sherman, C. Jillian Tsai, Shrujal S. Baxi, Jahan Aghalar
Journal of Clinical Oncology. 2021-01-01 - 18 citationsEverolimus plus bevacizumab is an effective first-line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trialDarren R. Feldman, Yasser Ged, Chung-Han Lee, Andrea Knezevic, Ana M. Molina
Cancer. 2020-12-15
Press Mentions
The a-list: Long Island’s Top Prostate Cancer OncologistsSeptember 6th, 2024- Clinical Trials and New Techniques Bring Advances in the Treatment of Bladder CancerJune 4th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
